Biotech

All Articles

Galapagos stops CAR-T cell therapy trial over Parkinsonism instance

.Galapagos has actually stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue therapy...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After much more than thirty years, gene treatment trailblazer James Wilson M.D., Ph.D., is leaving ...

3 biotechs make an effort to trump the summer season warmth through losing staff

.As biotechs seek to switch a fresh page in August, a minimum of three firms have actually lost team...

venBio raises $528M for 5th lifestyle sciences VC fund

.Expert financial backing organization venBio has actually raised another half a billion dollars to ...

Otsuka spends $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Drug has grabbed Boston-based Jnana Therapeutics for $800 million so the Eastern biotech can...

FibroGen lays off 75% people workers as property fails 2 even more trials

.FibroGen is significantly restructuring its own organization, laying off 75% of its own USA workers...

Tracon unwind full weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has chosen to relax operations weeks after an injectable immune checkpoint i...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on stopped working epilepsy medicine, boasts FDA manage

.Our team currently understand that Takeda is actually intending to discover a course to the FDA for...

VBI Vaccinations apply for insolvency, looks for resource sale

.Immunology biotech VBI Vaccinations is turning hazardously close to the defining moment, with plans...